
The FDA has approved a supplemental new drug application for Valtrex (valacyclovir HCI) manufactured by GlaxoSmithKline.

The FDA has approved a supplemental new drug application for Valtrex (valacyclovir HCI) manufactured by GlaxoSmithKline.

When a Division of Dermatology in Wright State's College of Medicine placed a newspaper ad to recruit volunteers for a tattoo-removal study, more than 100 people responded.

In Texas, voters approved a constitutional amendment limiting medical malpractice awards.

Galderma Laboratories has formed a new sales division, Theracutix, which will supplement the company's two current sales divisions: Galderma and CutiScience.

Ecolab Inc. sold the consumer dermatology business of its Adams Healthcare subsidiary to Britain's Ferndale Pharmaceuticals Ltd.

The U.S. Army offers a website to help aspiring healthcare professionals.

Cytochroma Inc. discovered a new gene ? CYP26C ? which encodes a retinoic-acid-metabolizing enzyme.

MacroChem Corporation has formed a scientific advisory board to help the company in evaluating new applications for its current transdermal technologies.

Helix BioMedix completed a preliminary study designed to evaluate the efficacy of one the company's proprietary peptides, HB64, in reducing severity of mild to moderate acne symptoms.

Enfis, a Wales-based company, is working to bring to market a laser designed to cure acne and has been given the go-ahead to start clinical trials.

Biologics manufacturers cite complex research and development process,along with FDA scrutiny, as reason for costly - but worthy - drugs

Database consolidates drug safety, effectiveness data to fully leverageemerging research findings on biologic

New efficacy and safety data continue to impress

San Francisco - While formal studies have yet to be conducted, an emerging injection technique for facial-fat grafting seems to add volume to the aging face with long-lasting if not permanent results and without fear of allergic reactions. The technique, called fat autograft muscle injection (FAMI), appears loaded with potential benefits for physicians and patients, according to unpublished data compiled by Stephen H. Mandy, M.D. clinical professor of dermatology, University of Miami School of Medicine.

In order to avoid the complications that can present from a surgical eyebrow lift, a study was conducted to test a nonsurgical, noninvasive eyebrow lift method.

Information about topical minoxidil in treating androgenetic alopecia was gleaned from a year-long study of men with AGA.

Cynosure Inc. has received additional government clearance for Apogee lasers, which can be used for pigmented lesion treatments and permanent hair removal.

An scientist's accident has led to the development of a blood-clotting powder that works on contact and reportedly is being sold at CVS and Walgreens.

Diabetics with ulcer sores on their feet that are difficult to treat may be helped by the use of Or-cel, a collagen sponge containing human cells.

Cyanotech, a Hawaiian company, reportedly is growing a patented substance in man-made ponds that it claims can help prevent sunburns.

AlphaMed Inc. announced that it received a $500,000 two-year STTR Phase II grant award from the National Cancer Institute to further develop a targeted radiotherapy for metastatic melanoma.

New research suggests that higher levels of sun exposure during childhood and early adolescence and greater actinic damage are associated with a reduced risk of developing multiple sclerosis.

Photocure ASA's photodynamic therapy, Metvix (methylaminolevulinate) is scheduled for review this month as a basal cell carcinoma treatment.

Topical tacrolimus is effective in treating anogenital lichen sclerosus, according to two case reports in the July issue of the Archives of Dermatology.

The department of surgery, LTMG Hospital and LTM Medical College in India strongly recommends the use of banana-leaf dressings for partial thickness burn wounds.